tibolone: Clinical Trials

12 trials of tibolone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 unknown, 1 terminated. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 8, Unknown 3, Terminated 1

Follow tibolone: new trials by email Literature Review of tibolone trials Research Report on tibolone

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
the Effects of Different Therapy Regimens on Menopausal Sleep Disorders
Tibolone, Xiangshao granules, Tibolone plus Xiangshao granules - Menopause, Sleep Disorder
Phase 4UnknownPeking Union Medical College Hospital1802023-12-302024-01-02
Psychological Impact of Amenorrhea in Women With Endometriosis
Estroprogestinic therapy (Etinil-estradiol/levonorgestre), Gonadotropin-releasing hormone agonist (Leuprorelin acetate), Add back therapy 1 (tibolone) - Amenorrhea, Endometriosis
Phase 4UnknownUniversity of Cagliari502021-06-012021-02-04
The Impact of Hormone Therapy on Lower Urinary Tract Symptoms, Sexual Function and Psychosomatic Disorder
Tibolone, Estradiol & medroxyprogesterone acetate - Menopausal Syndromes
Phase 4CompletedFar Eastern Memorial Hospital1252012-11-162022-02-23
Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression
Tibolone - Menopausal Depression
Phase 4CompletedThe Alfred1202012-07-012020-01-09
Investigation of Tibolone and Escitalopram in Perimenopausal Depression
Tibolone, Escitalopram, Natvia - Perimenopausal Depression
Phase 4TerminatedThe Alfred22012-07-012015-03-31
Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis
gonadotropin-releasing-hormone agonist (GnRHa) - Goserelin - Endometriosis
Phase 4UnknownZhejiang University602008-03-012011-03-15
Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women
17B Estradiol (1mg) / (0.125 mg) TMG Continuous combined (Totelle), Tibolone (Livial) - Vasomotor Symptoms
Phase 4CompletedWyeth is now a wholly owned subsidiary of Pfizer2042006-02-012010-10-29
Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women
17ß-Estradiol/Dydrogesterone, Tibolone - Menopause
Phase 4CompletedSolvay Pharmaceuticals1352005-11-012009-04-01
High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone
fenofibrate and tibolone, tibolone - HDL Cholesterol
Phase 4CompletedKeogh Institute for Medical Research202005-08-012010-02-02
Effects of Tibolone Treatment on the Endometrium
Tibolone, Estradiol, Estradiol + Medroxy Progesterone Acetate - Postmenopause, Osteoporosis
Phase 4CompletedErasmus Medical Center352003-02-012006-02-22
Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)
tibolone, low-dose estradiol/noresterone - Menopause
Phase 4CompletedOrganon and Co5702002-11-012022-02-03
Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090)
tibolone, raloxifen - Osteopenia
Phase 4CompletedOrganon and Co3242000-07-312024-08-15

Conditions studied

Depression (2)  ·  Endometriosis (2)  ·  Amenorrhea (1)  ·  Bone Diseases, Metabolic (1)  ·  Osteoporosis (1)  ·  Recurrence (1)  ·  Sleep Wake Disorders (1)

Sponsors

Organon and Co (2)  ·  The Alfred (2)  ·  Erasmus Medical Center (1)  ·  Far Eastern Memorial Hospital (1)  ·  Keogh Institute for Medical Research (1)  ·  Peking Union Medical College Hospital (1)  ·  Solvay Pharmaceuticals (1)  ·  University of Cagliari (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)  ·  Zhejiang University (1)

Countries

Australia (3)  ·  Italy (2)  ·  China (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Taiwan (1)

Top investigators

Jayashri Kulkarni, PhD,FRANZP (2)  ·  Bronwyn G Stuckey, MBBS FRACP (1)  ·  Curt W Burger, MD, PhD (1)  ·  Gerald F Watts, MD PhD FRACP (1)  ·  Hugh Barrett, BAgSc PhD (1)  ·  Leen J Blok, PhD (1)  ·  Rong Chen, Professor (1)  ·  Rosalind Hampton, BSc MBBS (1)  ·  Xinmei Zhang, Prof. (1)

Results publications

PMID 17995496, PMID 18077316, PMID 18256777, PMID 29723767, PMID 37882059

NIH funding

2004 (1)